PTPRC and neoplasm: Murine polymorphonuclear leukocytes (PMNs) are distinguished by gating on cells that are CD45+ CD11b+ Ly6G+ Ly6Clow.10 PMNs comprise several myeloid immune cell populations that are capable of both inhibiting and promoting tumor cell activity.